Elp3-mediated codon-dependent translation promotes mTORC2 activation and regulates macrophage polarization.
Elp3
mTORC2
macrophage polarization
mitochondrial translation
tRNA modifications
Journal
The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664
Informations de publication
Date de publication:
15 09 2022
15 09 2022
Historique:
revised:
05
07
2022
received:
02
08
2021
accepted:
07
07
2022
pubmed:
4
8
2022
medline:
17
9
2022
entrez:
3
8
2022
Statut:
ppublish
Résumé
Macrophage polarization is a process whereby macrophages acquire distinct effector states (M1 or M2) to carry out multiple and sometimes opposite functions. We show here that translational reprogramming occurs during macrophage polarization and that this relies on the Elongator complex subunit Elp3, an enzyme that modifies the wobble uridine base U34 in cytosolic tRNAs. Elp3 expression is downregulated by classical M1-activating signals in myeloid cells, where it limits the production of pro-inflammatory cytokines via FoxO1 phosphorylation, and attenuates experimental colitis in mice. In contrast, alternative M2-activating signals upregulate Elp3 expression through a PI3K- and STAT6-dependent signaling pathway. The metabolic reprogramming linked to M2 macrophage polarization relies on Elp3 and the translation of multiple candidates, including the mitochondrial ribosome large subunit proteins Mrpl3, Mrpl13, and Mrpl47. By promoting translation of its activator Ric8b in a codon-dependent manner, Elp3 also regulates mTORC2 activation. Elp3 expression in myeloid cells further promotes Wnt-driven tumor initiation in the intestine by maintaining a pool of tumor-associated macrophages exhibiting M2 features. Collectively, our data establish a functional link between tRNA modifications, mTORC2 activation, and macrophage polarization.
Identifiants
pubmed: 35920020
doi: 10.15252/embj.2021109353
pmc: PMC9475509
doi:
Substances chimiques
Codon
0
Elp3 protein, mouse
EC 2.3.1.48
Histone Acetyltransferases
EC 2.3.1.48
Mechanistic Target of Rapamycin Complex 2
EC 2.7.11.1
Banques de données
GEO
['GSE166169']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e109353Informations de copyright
© 2022 The Authors. Published under the terms of the CC BY 4.0 license.
Références
Proteomics. 2007 Oct;7(20):3672-80
pubmed: 17880000
Science. 1992 May 1;256(5057):668-70
pubmed: 1350108
Immunity. 2015 Mar 17;42(3):419-30
pubmed: 25786174
Nat Commun. 2013;4:2834
pubmed: 24280772
J Exp Med. 1992 Jul 1;176(1):287-92
pubmed: 1613462
Mol Cell Biol. 1999 Sep;19(9):6195-206
pubmed: 10454566
J Immunol. 2010 Jul 1;185(1):605-14
pubmed: 20498354
Sci Adv. 2019 Jun 19;5(6):eaav0184
pubmed: 31223645
Nat Immunol. 2020 May;21(5):501-512
pubmed: 32284591
Annu Rev Genet. 2012;46:69-95
pubmed: 22905870
J Immunol. 2021 Mar 1;206(5):1077-1087
pubmed: 33483347
Science. 1994 Sep 16;265(5179):1701-6
pubmed: 8085155
PLoS One. 2014 Apr 16;9(4):e95432
pubmed: 24740015
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
Trends Endocrinol Metab. 2011 Mar;22(3):94-102
pubmed: 21269838
J Biol Chem. 2011 Dec 30;286(52):44295-305
pubmed: 22045807
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
Nature. 2018 Jun;558(7711):605-609
pubmed: 29925953
Cell. 1999 Mar 19;96(6):857-68
pubmed: 10102273
J Exp Med. 2015 Nov 16;212(12):2057-75
pubmed: 26527802
Science. 2012 Jul 27;337(6093):431-5
pubmed: 22837519
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33507234
Nat Rev Mol Cell Biol. 2020 Apr;21(4):183-203
pubmed: 31937935
Immunity. 2016 Oct 18;45(4):817-830
pubmed: 27760338
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5459-64
pubmed: 18391219
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
Cell Rep. 2012 May 31;1(5):424-33
pubmed: 22768388
Cell Metab. 2006 Jul;4(1):13-24
pubmed: 16814729
EMBO J. 2022 Sep 15;41(18):e109353
pubmed: 35920020
Front Immunol. 2015 May 19;6:225
pubmed: 26042120
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
Trends Cancer. 2017 Apr;3(4):249-252
pubmed: 28718436
Mol Cell. 2010 Jul 30;39(2):171-83
pubmed: 20670887
PLoS Genet. 2020 May 11;16(5):e1008255
pubmed: 32392211
Genes Dev. 2018 Dec 1;32(23-24):1472-1484
pubmed: 30463905
Dev Cell. 2015 Dec 7;35(5):553-567
pubmed: 26651292
Immunity. 2010 May 28;32(5):593-604
pubmed: 20510870
Circ Res. 2014 Apr 11;114(8):1268-80
pubmed: 24557881
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Nat Immunol. 2019 Feb;20(2):173-182
pubmed: 30559377
Nat Commun. 2017 Jan 27;8:14208
pubmed: 28128208
Cell Rep. 2016 Oct 11;17(3):625-626
pubmed: 27732839
Nat Immunol. 2017 Sep;18(9):985-994
pubmed: 28714978
Cell. 2015 Jun 18;161(7):1606-18
pubmed: 26052047
RNA Biol. 2021 Apr;18(4):563-575
pubmed: 32893724
Immunol Rev. 2017 Nov;280(1):102-111
pubmed: 29027220
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4557-76
pubmed: 25197329
FASEB J. 2018 Apr;32(4):2292-2304
pubmed: 29242277
J Exp Med. 2016 Oct 17;213(11):2503-2523
pubmed: 27811057
Sci Signal. 2020 Nov 17;13(658):
pubmed: 33203722
J Cell Physiol. 2013 Jul;228(7):1404-12
pubmed: 23065796
Annu Rev Immunol. 2020 Apr 26;38:289-313
pubmed: 31986069
Nucleic Acids Res. 2015 Jul 1;43(W1):W251-7
pubmed: 25897128